Lyndra Therapeutics

0 followers

‌

Lyndra Therapeutics is pioneering the first-ever oral, ultra-long-acting, sustained-release therapies, which have the potential to fundamentally change the way people take medicine by enabling patients to take a pill once a week rather than daily.

Industries

Employees

51-200

Links

Org chart

Jessica Ballinger
President & COO
Rosemary Kanasty
Senior Director, Platform Discovery
Colin Gardner
Co-Founder
Klas Holmlund, CFA
Chief Financial Officer
Lindsay Beaupre
Chief Administrative Officer
Patrick Boen
Vice President Clinical Development
Anna Legedza
Director, Biostatistics
Maureen Chlopik
Vice President
Michelle O'Connor
Associate Director, Analytical Research And Development
Samuel Chadwick
Director, Engineering & Industrialization
Roman Lovell
Senior Associate Engineer
Nicholas Barner
Associate Engineer
Liah Dukaye
Engineer Ii, Techops
Kiera Henderson
Engineer II
Jonathan Raber
Manufacture Engineer
Erik Ryde
Associate Director
Kevin Acreman
Process Engineering Lead, MS&T

Board & advisors

Amy Schulman
Executive Chair, Co-Founder
Zafrira Avnur
Board Member
Robert Langer
Co-Founder & Board Member
Giovanni Traverso
Co-Founder & Board Member
Douglas Dachille
Board Member
Jillian Moo-Young
Board Member
Kevin G. Guise
Board Member